Verruciform xanthoma: localized lymphedema (elephantiasis) is an essential pathogenic factor
Song Lu MD, PhD,
Angela Rohwedder PhD, Michael Murphy MD,
J. Andrew Carlson MD, FRCPC,
Song Lu MD, PhD
Department of Pathology, University of Maryland, Baltimore, MD, USA
Search for more papers by this authorMichael Murphy MD
Department of Dermatology, University of Connecticut Medical Center, Framington, CT, USA
Search for more papers by this authorCorresponding Author
J. Andrew Carlson MD, FRCPC
Divisions of Dermatopathology and Dermatology, Albany Medical College MC-81, Albany, NY, USA
e-mail: [email protected]Search for more papers by this authorSong Lu MD, PhD,
Angela Rohwedder PhD, Michael Murphy MD,
J. Andrew Carlson MD, FRCPC,
Song Lu MD, PhD
Department of Pathology, University of Maryland, Baltimore, MD, USA
Search for more papers by this authorMichael Murphy MD
Department of Dermatology, University of Connecticut Medical Center, Framington, CT, USA
Search for more papers by this authorCorresponding Author
J. Andrew Carlson MD, FRCPC
Divisions of Dermatopathology and Dermatology, Albany Medical College MC-81, Albany, NY, USA
e-mail: [email protected]Search for more papers by this author
References
- 1 Cumberland L, Dana A, Resh B, Fitzpatrick J, Goldenberg G. Verruciform xanthoma in the setting of cutaneous trauma and chronic inflammation: report of a patient and a brief review of the literature. J Cutan Pathol 2010; 37: 895.
- 2 Rohwedder A, Murphy M, Carlson JA. Multiple human papillomavirus DNA identified in verruciform xanthoma by nested polymerase chain reaction with degenerate consensus primers. J Cutan Pathol 2003; 30: 344; author reply 7.
- 3 Rohwedder A, Murphy M, Carlson JA. HPV in verruciform xanthoma–sensitivity and specificity of detection methods and multiplicity of HPV types affect results. J Cutan Pathol 2003; 30: 219; author reply 20–1.
- 4 Carlson JA, Rohwedder A, Dolph J, Murphy M. Hypothesis: lymphatic obstruction in combination with infection by human papillomavirus is responsible for development of verruciform xanthoma. Dermatopathology: Practical & Conceptual [serial on the Internet]. 2003; 9. Available from http://www.Derm101.com [accessed on 15 October 2010].
- 5 Lu S, Tran TA, Jones DM, et al. Localized lymphedema (elephantiasis): a case series and review of the literature. J Cutan Pathol 2009; 36: 1.
- 6 Ryan TJ. Structure and function of lymphatics. J Invest Dermatol 1989; 932 Suppl.: 18S.
- 7 Angeli V, Randolph GJ. Inflammation, lymphatic function, and dendritic cell migration. Lymphat Res Biol 2006; 4: 217.
- 8 Paul J, Carlson JA. Lymphangiectases are common underlying warts and in normal peri-tumoral skin: histologic evidence of decreased immune surveillance. Amer J Dermatopathol 2011. [Epub 1 February 2011; DOI: 10.1097/DAD.0b013e3181ef2d65]
- 9 Ruocco E, Puca RV, Brunetti G, Schwartz RA, Ruocco V. Lymphedematous areas: privileged sites for tumors, infections, and immune disorders. Int J Dermatol 2007; 46: 662.
- 10 Ruocco V, Schwartz RA, Ruocco E. Lymphedema: an immunologically vulnerable site for development of neoplasms. J Am Acad Dermatol 2002; 47: 124.
- 11 Goldrick RB, Ahrens EH Jr. Unilateral chylous lymphedema and xanthomatosis: a study of factors governing the flow of intestinal lymph. Am J Med 1964; 37: 610.
- 12 Hunter JA, Morley WN, Peterkin GA. Xanthomatosis secondary to lymphoedema. Trans St Johns Hosp Dermatol Soc 1970; 56: 143.
- 13 Snider RL. Verruciform xanthomas and lymphedema. J Am Acad Dermatol 1992; 27(6 Pt 1): 1021.
- 14 Woolling KR, Jenkins RE, Dolan PA, Evans PV. Localized xanthomas in lymphedema praecox. JAMA 1970; 211: 1372.
- 15 Polano MK, Prins FJ. Lymphangiectasis and secondary xanthomatosis. Hautarzt 1965; 16: 86.
- 16 Shafer WG. Verruciform xanthoma. Oral Surg Oral Med Oral Pathol 1971; 31: 784.
- 17 Carlson JA, Ambros R, Malfetano J, et al. Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia. Hum Pathol 1998; 29: 932.
- 18 Friedewald WF. Cell state as affecting susceptibility to a virus: enhanced effectiveness of the rabbit papilloma virus on hyperplastic epidermis. J Exp Med 1942; 75: 197.
- 19 Antonsson A, Karanfilovska S, Lindqvist PG, Hansson BG. General acquisition of human papillomavirus infections of skin occurs in early infancy. J Clin Microbiol 2003; 41: 2509.
- 20 Antonsson A, Forslund O, Ekberg H, Sterner G, Hansson BG. The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol 2000; 74: 11636.
- 21
de Villiers EM,
Lavergne D,
McLaren K,
Benton EC.
Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients.
Int J Cancer
1997; 73: 356.
10.1002/(SICI)1097-0215(19971104)73:3<356::AID-IJC9>3.0.CO;2-Z CAS PubMed Web of Science® Google Scholar
- 22 Antonsson A, Erfurt C, Hazard K, et al. Prevalence and type spectrum of human papillomaviruses in healthy skin samples collected in three continents. J Gen Virol 2003; 84(Pt 7): 1881.
- 23 Broker TR, Jin G, Croom-Rivers A, et al. Viral latency–the papillomavirus model. Dev Biol (Basel) 2001; 106: 443; discussion 52–3, 65–75.
- 24 Mosovich B, Gatot A, Zirkin H. Widespread oral papillomatosis due to chronic buccal trauma. Cutis 1989; 43: 254.
- 25 Keefe M, al-Ghamdi A, Coggon D, et al. Cutaneous warts in butchers. Br J Dermatol 1994; 130: 9.
- 26 Roach MC, Chretien JH. Common hand warts in athletes: association with trauma to the hand. J Am Coll Health 1995; 44: 125.
- 27 French A, Masters E. Warts from minor trauma. Lancet 2002; 359: 760.
- 28 Loo SK, Tang WY. Warts (non-genital). Clin Evid (Online) [serial on the Internet]. 2009; 09. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19454080 [accessed on 15 October 2010].
- 29 Mu XC, Tran TA, Dupree M, Carlson JA. Acquired vulvar lymphangioma mimicking genital warts. A case report and review of the literature. J Cutan Pathol 1999; 26: 150.
- 30 Földi E, Földi M. Lymphostatic diseases. In M Földi, E Földi, eds. Földi's textbook of lymphology. Munich: Elsevier GmbH, 2006; 224.
- 31
Iamaroon A,
Vickers RA.
Characterization of verruciform xanthoma by in situ hybridization and immunohistochemistry.
J Oral Pathol Med
1996; 25: 395.
10.1111/j.1600-0714.1996.tb00285.x Google Scholar
- 32 Khaskhely NM, Uezato H, Kamiyama T, et al. Association of human papillomavirus type 6 with a verruciform xanthoma. Am J Dermatopathol 2000; 22: 447.
- 33
Helm KF,
Hopfl RM,
Kreider JW,
Lookingbill DP.
Verruciform xanthoma in an immunocompromised patient: a case report and immunohistochemical study.
J Cutan Pathol
1993; 20: 84.
10.1111/j.1600-0560.1993.tb01256.x Google Scholar
- 34 Ersahin C, Szpaderska AM, Foreman K, Yong S. Verruciform xanthoma of the penis not associated with human papillomavirus infection. Arch Pathol Lab Med 2005; 129: e62.
- 35
Nakamura S,
Kanamori S,
Nakayama K,
Aoki M.
Verruciform xanthoma on the scrotum.
J Dermatol
1989; 16: 397.
10.1111/j.1346-8138.1989.tb01288.x Google Scholar
- 36
Connolly SB,
Lewis EJ,
Lindholm JS,
Zelickson BD,
Zachary CB,
Tope WD.
Management of cutaneous verruciform xanthoma.
J Am Acad Dermatol
2000; 42(2 Pt 2): 343.
10.1016/S0190-9622(00)90108-7 Google Scholar
- 37
Mohsin SK,
Lee MW,
Amin MB, et al.
Cutaneous verruciform xanthoma: a report of five cases investigating the etiology and nature of xanthomatous cells.
Am J Surg Pathol
1998; 22: 479.
10.1097/00000478-199804000-00014 Google Scholar
- 38 Furue M, Suzuki H, Kodama T, Hiramoto T, Sugiyama H, Tamaki K. Colocalization of scavenger receptor in CD68 positive foam cells in verruciform xanthoma. J Dermatol Sci 1995; 10: 213.
- 39
Orchard GE,
Wilson Jones E,
Russell Jones R.
Verruciform xanthoma: an immunocytochemical study.
Br J Biomed Sci
1994; 51: 28.
10.1016/0030-4220(74)90393-4 Google Scholar
- 40 Barr RJ, Plank CJ. Verruciform xanthoma of the skin. J Cutan Pathol 1980; 7: 422.
- 41 Ackerman AB, Mones J. Verruciform xanthoma? In Ackerman AB, ed. Ackerman's resolving quandaries in dermatology, pathology, and dermatopathology. New York: Ardor Scribendi, 2001; 409.
- 42 Kalof AN, Cooper K. D2-40 immunohistochemistry–so far! Adv Anat Pathol 2009; 16: 62.